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hagocyte recognition and clearance of bacteria
play essential roles in the host response to infec-
tion. In an on-going forward genetic screen, we
identify the 
 
Drosophila melanogaster 
 
scavenger receptor
Croquemort as a receptor for 
 
Staphylococcus aureus
 
,
implicating for the ﬁrst time the CD36 family as phago-
cytic receptors for bacteria. In transfection assays, the
mammalian Croquemort paralogue CD36 confers bind-
ing and internalization of Gram-positive and, to a lesser
extent, Gram-negative bacteria. By mutational analysis,
we show that internalization of 
 
S. aureus
 
 and its compo-
nent lipoteichoic acid requires the COOH-terminal cyto-
P
 
plasmic portion of CD36, speciﬁcally Y463 and C464,
which activates Toll-like receptor (TLR) 2/6 signaling.
Macrophages lacking CD36 demonstrate reduced inter-
nalization of 
 
S. aureus
 
 and its component lipoteichoic
acid, accompanied by a marked defect in tumor necrosis
factor-
 
 
 
 and IL-12 production. As a result, 
 
Cd36
 
 
 
/
 
 
 
mice fail to efﬁciently clear 
 
S. aureus
 
 in vivo resulting in
profound bacteraemia. Thus, response to 
 
S. aureus
 
 re-
quires CD36-mediated phagocytosis triggered by the
COOH-terminal cytoplasmic domain, which initiates
TLR2/6 signaling.
 
Introduction
 
Phagocytosis plays an important role in first line host defense.
Phagocytic cells, such as macrophages and dendritic cells,
must efficiently differentiate “infectious nonself” from “non-
infectious self” and initiate an appropriate inflammatory re-
sponse (Hoffmann et al., 1999). Central to this process is the
expression of pattern recognition receptors, such as the scaven-
ger receptors (SRs), which bind a broad array of modified and
foreign ligands (Mukhopadhyay and Gordon, 2004). The B
class SR CD36 is an 88-kD glycoprotein expressed by myeloid
cells, platelets, endothelial cells, erythroid precursors, and adi-
pocytes (Febbraio et al., 2001). This multifunctional receptor
mediates homeostatic functions, including adhesion to throm-
bospondin and collagen, transport of long-chain fatty acids,
and inhibition of angiogenesis (Febbraio et al., 2001). CD36
also shares with its 
 
Drosophila melanogaster 
 
paralogue,
Croquemort, the ability to recognize apoptotic cells (Savill et
al., 1992; Franc et al., 1999). In addition to these scavenging func-
tions, CD36 has been implicated in the innate immune response
to modified host ligands such as oxidized lipoproteins and
fibrillar 
 
 
 
-amyloid, as well as foreign antigens such as the
Pfemp antigen of 
 
Plasmodium falciparum
 
 (Ockenhouse and
Chulay, 1988; Oquendo et al., 1989; Endemann et al., 1993;
Moore et al., 2002; Medeiros et al., 2004). Intriguingly, human
CD36 mutations predicted to result in the loss of the COOH-
terminal transmembrane domain and cytoplasmic tail (T1264G
and G1439C) are relatively common in certain African and Asian
populations (occurring at high frequency between 0.5–2%), but
are extremely uncommon in Caucasians (Aitman et al., 2000).
This suggests that selection pressures exist to maintain or
eliminate CD36 mutations within certain populations, and
these may include interactions with pathogens. Two such inter-
actions may be CD36-mediated recognition of 
 
P. falciparum
 
 in
malaria and a more recently identified role as a candidate re-
ceptor for lipoteichoic acid (LTA), a cell wall component of
the Gram-positive bacterium 
 
Staphylococcus aureus
 
 (Hoebe
et al., 2005). However, the mechanism by which CD36 partic-
ipates in the response to pathogens and their ligands and the
consequences of CD36 mutations on the host defense have
not been defined.
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charide; LTA, lipoteichoic acid; RNAi, RNA interference; SR, scavenger receptor;
TLR, Toll-like receptor. 
JCB • VOLUME 170 • NUMBER 3 • 2005 478
 
Mammalian pattern recognition receptors have evolved
to identify highly conserved pathogen-associated molecular
patterns essential to microbes’ existence or pathogenicity, in-
cluding bacterial lipopolysaccharide (LPS), LTA, peptidogly-
can, bacterial CpG-containing DNA, double-stranded RNA, or
mannans. A family of receptors related to Toll, a 
 
Drosophila
 
receptor involved in dorsal ventral patterning, have emerged
as key regulators in the host response to invading pathogens
(Akira and Takeda, 2004). The mammalian Toll-like receptor
(TLR) family has 10 members, which each recognize a distinct
subset of microbial molecules from bacteria, viruses, fungi,
and protozoa to activate common signaling pathways that ini-
tiate the innate immune response (Akira and Takeda, 2004).
The best-characterized TLR is perhaps TLR4, which cooper-
ates with the glycosylphosphatidylinositol-anchored protein
CD14 to mediate the signaling response to bacterial LPS
(Akira and Takeda, 2004). Although the exact mechanism has
yet to be defined, CD14 is believed to cluster LPS at the cell
surface where it can deliver this ligand to TLR4. A precedent
is emerging for similar cooperation between TLRs and other
molecules. As an example, dectin-1, a C-type lectin phagocytic
receptor, has been shown to cooperate with TLR2 in mediating
response to zymosan (Gantner et al., 2003). Additionally,
Rac1, a small Rho-GTPase involved in phagocytosis, has been
shown to be required for TLR2-mediated activation of NF
 
 
 
B
by 
 
S. aureus
 
 (Arbibe et al., 2000). Intriguingly, although many
TLRs are found on the cell surface, members of this family
also localize to endosomes, lysosomes, or the Golgi apparatus
(Underhill et al., 1999; Underhill and Gantner, 2004), raising
the possibility that these cooperative interactions exist to fa-
cilitate ligand delivery to the appropriate compartment after
endocytosis or phagocytosis for efficient activation of the
immune response.
Here, we show that CD36 and its 
 
Drosophila
 
 paralogue
Croquemort have a similar role in tethering bacteria and de-
rived ligands. This recognition plays an important role in initi-
ating macrophage cytokine production in response to 
 
S. aureus,
 
its cell wall component LTA, and, to a lesser extent, Gram-
negative 
 
E. coli
 
 and its derived ligand, LPS. We demonstrate
that the COOH-terminal cytoplasmic domain, which is lost in
several of the common human mutations of CD36, is required
for bacterial internalization and cooperation with TLR2, sug-
gesting that individuals carrying these mutations may be more
susceptible to 
 
S. aureus
 
 infection. Mice deficient in CD36
demonstrate a marked defect in the host response to 
 
S. aureus
 
but not 
 
E. coli
 
. A combined defect in cytokine response and
bacterial phagocytosis in CD36 null mice results in profound
bacteraemia and the formation of tissue abscesses. We sug-
gest that like CD14, CD36 functions as an accessory receptor
at the cell surface to present bacterial ligands to their cognate
TLRs to initiate signaling (Lien et al., 1999; Schwandner et
al., 1999; Morr et al., 2002). Furthermore, through its ability
to internalize 
 
S. aureus
 
 and LTA, CD36 also delivers ligands
to TLRs recruited to the phagosome/endosome (Underhill et
al., 1999).
 
Results
 
The 
 
Drosophila
 
 CD36 paralogue 
Croquemort is a receptor for 
 
S. aureus
 
In an on-going high-throughput RNA interference (RNAi)
screen for 
 
Drosophila
 
 genes involved in phagocytosis, we
identified that the SR Croquemort showed a specific inhibition
of phagocytosis of 
 
S. aureus
 
 but not 
 
E. coli
 
 (Fig. 1 a). 
 
Drosoph-
ila
 
 S2 cells treated with RNAi to target Croquemort showed
a 35% decrease in their ability to internalize 
 
S. aureus
 
, whereas
targeting of an irrelevant control gene (GFP) showed no effect
on bacterial internalization (unpublished data). Mammalian
Rac has been shown to have an important role in responses to
 
S. aureus
 
 (Arbibe et al., 2000). Therefore, we tested whether
Rho-GTPase family members played a role in 
 
S. aureus
 
 uptake
in 
 
Drosophila
 
. Silencing of Rac2, but not Rac1, resulted in a
specific defect in 
 
S. aureus
 
 internalization comparable to that
seen with Croquemort inhibition, providing circumstantial evi-
dence that Croquemort may activate this Rho-GTPase to medi-
ate downstream phagocytosis. These results suggest that
Croquemort and Rac2 play nonredundant roles in the recogni-
tion and internalization of 
 
S. aureus
 
 in 
 
Drosophila
 
. However,
lethality of Croquemort deficient flies precluded further study
of the role of this molecule in innate immune defense in this in-
vertebrate system.
Figure 1. The Drosophila protein Croquemort and its mammalian para-
logue CD36 are receptors for S. aureus. (a) Croquemort and the small
GTPase Rac2 are specifically required for S. aureus binding and uptake.
RNAi silencing of Croquemort (Crq) and Rac2 in Drosophila S2 cells re-
duced phagocytosis of S. aureus (left), but not E. coli (right). *, P   0.05;
**, P   0.001; significantly different from control. (b and c) Expression of
CD36 confers cellular binding and internalization of S. aureus and E. coli.
(b) HEK293T-CD36 expressing cells (CD36; filled bars) demonstrate a
threefold increase in binding of FITC-labeled S. aureus and a twofold in-
crease in binding of FITC-labeled E. coli over vector-transfected cells
(Mock; open bars). *, P   0.05. (c) Expression of CD36 by HEK293 cells
confers a threefold increase in internalization of both FITC-labeled S. aureus
and E. coli, as compared with vector-transfected cells (Mock; open bars).
*, P   0.05. 
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CD36 transfection confers both binding 
and internalization of 
 
S. aureus
 
 and 
 
E. coli
 
The mammalian SR CD36 is paralogous to Croquemort, and
these receptors share the ability to bind apoptotic cells, indicat-
ing that they have overlapping ligand specificities (Savill et al.,
1992; Franc et al., 1999). Therefore, our observation that
Croquemort mediated engulfment of 
 
S. aureus
 
 raised the possi-
bility that CD36 might also function as a mammalian receptor
for Gram-positive bacteria. Thus, to test the ability of CD36 to
phagocytose bacteria, we measured binding and internalization
of fluorescently labeled 
 
S. aureus
 
 and 
 
E. coli
 
 in human embry-
onic kidney (HEK) 293T cells transfected with a murine CD36
cDNA. Expression of CD36 conferred a threefold increase in
binding of 
 
S. aureus
 
 and a twofold increase with 
 
E. coli 
 
over
mock transfected control cells (Fig. 1 b). Furthermore, expres-
sion of CD36 resulted in a threefold increase in cellular inter-
nalization of bacteria (Fig. 1 c), indicating that CD36 acts as a
phagocytic receptor for both Gram-positive and, to a lesser ex-
tent, Gram-negative bacteria.
 
Tyrosine 463 within the COOH-terminal 
cytoplasmic tail of CD36 is required to 
signal engulfment
 
The COOH-terminal cytoplasmic tail of CD36 is lacking in sev-
eral common human CD36 mutations (Aitman et al., 2000), and
this domain is postulated to interact with signaling molecules
(Huang et al., 1991; Bull et al., 1994; Jimenez et al., 2000;
Moore et al., 2002). Thus, we addressed the consequences of the
lack of the COOH-terminal region on phagocytosis of 
 
S. aureus
 
using structure–function analysis. To determine the minimum
requirements for CD36 to signal to the actin cytoskeleton and
trigger engulfment, HEK293T cells were transfected either with
wild-type CD36 (CD36
 
WT
 
) or with a mutant form of CD36 in
which the 11 COOH-terminal cytoplasmic amino acid residues
had been replaced by alanines (CD36
 
Ala
 
; Fig. 2 a). Equivalent
cell surface expression of CD36
 
WT
 
 and CD36
 
Ala
 
 was confirmed
by flow cytometry (Fig. 2 b) and bacterial phagocytosis was
measured. Importantly, mutant constructs demonstrated a 
 
 
 
3%
difference in cell surface expression in all experiments, indicat-
ing that the tail was not required for cell surface localization.
Transfection of CD36
 
WT
 
 and CD36
 
Ala
 
 resulted in a twofold in-
crease in bacterial binding; however, only CD36
 
WT
 
 conferred 
 
S.
aureus
 
 phagocytosis, suggesting that the COOH-terminal tail of
CD36 is required to signal the actin cytoskeleton (Fig. 2 c). In-
cluded in these COOH-terminal amino acids is a tyrosine resi-
due which, as a potential site of phosphorylation, could provide
a docking site for SH2 domain–containing proteins, such as the
Src family of tyrosine kinases and the actin regulator p130Cas.
Thus, to further define the region responsible for signaling in-
ternalization, we mutated this tyrosine at position 463 to phenyl-
alanine (CD36
 
Y463F
 
). Cells transfected with the CD36
 
Y463F
 
 mu-
tant bound 
 
S. aureus
 
, but, similar to CD36
 
Ala
 
, showed an
impairment of phagocytosis, indicating that tyrosine 463 is es-
sential for CD36-mediated bacterial internalization (Fig. 2 c).
Together, these data indicate that the COOH-terminal cytoplas-
mic tail of CD36 regulates receptor-mediated internalization of
 
S. aureus
 
 and implicates tyrosine 463 in signaling to the actin
cytoskeleton. Thus, we would predict that the reported human
CD36 mutations would also be unable to trigger internalization
in response to this organism.
 
CD36-deficient macrophages 
demonstrate impaired phagocytosis of
 
S. aureus
 
 and cytokine production
 
To define the consequences of lack of functional CD36 signal-
ing, we used CD36 null mice to evaluate phagocytosis and re-
sponse to 
 
S. aureus
 
, 
 
E. coli
 
, and their derived ligands. 
 
Cd36
 
 
 
/
 
 
 
macrophages showed a 40–50% reduction in phagocytosis of 
 
S.
aureus,
 
 but comparable levels of internalization of 
 
E. coli
 
 rela-
tive to wild-type macrophages (Fig. 3, a and c). This suggests a
relative specificity for Gram-positive organisms conserved be-
tween the 
 
Drosophila
 
 Croquemort protein and mammalian
CD36. LTA is an abundant cell wall component of 
 
S. aureus
 
that is released after exposure to antibiotics or leukocytic medi-
ators. To better identify the ligand present on 
 
S. aureus
 
 that is
recognized by CD36, we tested whether CD36 could bind and
internalize LTA. In concordance with our findings with whole
 
S. aureus
 
, 
 
Cd36
 
 
 
/
 
 
 
 macrophages demonstrated a 60% reduc-
tion in their ability to internalize BODIPY-LTA (Fig. 3 b), in-
dicating that CD36 mediates phagocytic/endocytic recognition
of this important TLR ligand.
 
Cd36
 
 
 
/
 
 
 
 macrophages treated with 
 
S. aureus for 4 h
showed a profound reduction (65–75%) in TNF  and IL-12
protein expression as compared with wild-type macrophages
Figure 2. Tyrosine 463 within the COOH-terminal cytoplasmic tail of
CD36 is required to signal engulfment of S. aureus. (a) Schematic drawing
of CD36 demonstrating the amino acid sequence of the COOH-terminal
tail and specific mutations. COOH-terminal mutations of the murine CD36
cDNA were generated by PCR, verified by sequencing, and used to
transfect HEK293T cells. (b) Before use in phagocytosis experiments,
equivalent cell surface expression of wild-type CD36 (CD36
wt) and CD36
mutants (CD36
Ala and CD36
Y463F) was verified by flow cytometry analysis.
(c) Transfection of CD36 COOH-terminal tail mutants fails to confer inter-
nalization (open bars), but permits binding (closed bars) of S. aureus.
**, P   0.005, significantly different from wild-type CD36.JCB • VOLUME 170 • NUMBER 3 • 2005 480
(Fig. 4 a). In addition, the absence of CD36 resulted in a mod-
est 25% decrease in the secretion of TNF  and IL-6 (no IL-12
was detected) in response to E. coli (Fig. 4 b). Together, these
data indicate that CD36 plays a larger role in the phagocytic
and cytokine response to S. aureus than E. coli. As the bacterial
ligands LTA and LPS make major contributions to septic shock
through their activation of TLR signaling pathways, we investi-
gated whether CD36 was required for their activation of cyto-
kine responses. Similar to our findings with S. aureus, Cd36
 / 
macrophages treated with LTA demonstrated a 60–70% defect
in TNF  and IL-12 expression (Fig. 5, a and b). Although
Cd36
 /  macrophages showed some reduction in TNF  and
IL-12 mRNA in response to LPS (Fig. 5 a), TNF  and IL-12
protein expression was not reduced (Fig. 5 b), militating
against a general inability of these cells to respond to proin-
flammatory ligands. Together, these data demonstrate that
CD36 mediates not only phagocytic/endocytic recognition of
LTA but also is required to initiate the cytokine response to this
ligand, suggesting that this receptor is an important adjunct to
the TLR signaling pathway.
CD36-mediated internalization by the 
COOH-terminal cytoplasmic domain is 
required for engagement of TLR2/6 
signaling
To define the mechanism of CD36 signaling in response to S.
aureus and LTA, and to investigate whether CD36 cooperates
with TLRs, we used stably transfected HEK293-TLR2 or -TLR9
expressing cell lines transfected with an NF B-luciferase re-
porter system. Transfection of either CD36 or TLR6 alone
caused a twofold increase in NF B activation in TLR2 ex-
pressing cells (Fig. 6 a). However, cotransfection of these re-
ceptors resulted in a 10-fold increase in NF B activation, indi-
cating that CD36 cooperates with the TLR2/6 heterodimer to
mediate LTA signaling. In response to LTA, CD36 did not co-
operate with TLR9, either in the presence or absence of TLR6,
demonstrating a specificity for the interaction of CD36 with
TLR2/6. CD36 was also found to augment TLR2/6 signaling in
response to S. aureus, but to a lesser extent than that observed
for LTA (Fig. 6 b; 6- vs. 12-fold increase in NF B activity).
As CD36 has the additional capacity to internalize li-
gands, we investigated whether CD36-mediated internaliza-
tion  contributes to activation of TLR2/TLR6 signaling by
blocking LTA internalization with cytochalasin D in HEK293-
TLR2 cells transfected with CD36, TLR6, or both. Inhibition
of LTA internalization abrogated CD36-initiated NF B activa-
tion, indicating a requirement for uptake to initiate TLR2/6 sig-
naling (Fig. 6 c). Similar to our findings with S. aureus, the
CD36
Ala mutation also blocked internalization of LTA, indicat-
ing a requirement for the COOH-terminal tail of the receptor
for internalization of not only whole bacteria but also of its cell
wall component, LTA (Fig. 6 d). To specifically map the re-
quirement for LTA uptake, we mutated Y463, C464, and C466
and found that only mutation of Y463 and C464, but not the
distal cysteine C466, inhibited LTA internalization. Having
shown that internalization was necessary for signaling, we
hypothesized that these mutations would also disrupt CD36
cooperation with TLR2/6. Similar to the inhibition of LTA
internalization, mutation of the entire COOH-terminal tail to
alanine resulted in a 70% decrease in NF B activation com-
Figure 3. CD36-deficient macrophages demonstrate impaired phagocy-
tosis of S. aureus and its component LTA. Peritoneal macrophages from
wild-type and Cd36
 /  mice were incubated with FITC-S. aureus or FITC-
E. coli (10:1 bacteria/cell; panel a) or 10  g/ml BODIPY-LTA (b), and
phagocytosis was measured by flow cytometry in the presence of trypan
blue. **, P   0.005, compared with wild-type macrophages. (c) Repre-
sentative photographs of wild-type and Cd36
 /  macrophages incubated
with FITC-S. aureus (green) and stained with DAPI (blue) to show individ-
ual nuclei. Macrophages were incubated with 10:1 bacteria/cell and al-
lowed to internalize bacteria for 30 min at 37 C. Cells were washed 3 
in PBS to remove extracellular bacteria and fixed with formaldehyde.
Figure 4. Cd36
 /  macrophages demonstrate
impaired early responses to whole S. aureus
and, to a lesser extent, E. coli. Wild-type and
Cd36
 /  macrophages were treated with 10:1
S. aureus (a) or E. coli (b) for 4 h, and TNF ,
IL-12, and IL-6 were measured in cell culture
supernatants. *, P   0.05; **, P   0.005, sig-
nificantly different from wild-type macrophages.CD36 MEDIATES THE HOST RESPONSE TO S. AUREUS • STUART ET AL. 481
pared with wild-type CD36. This deficit could be recapitulated
by mutation of either Y463 or C464, but not C466, confirming
that mutations that block internalization also block NF B induc-
tion (Fig. 6 e). This is supported by the finding that whereas cyto-
chalasin D inhibited signaling by wild-type CD36, no inhibi-
tion of this TLR2/6 signaling was observed with CD36
Ala or
CD36
Y463F (Fig. 6 f). Together, these data indicate that CD36-
mediated internalization and cooperation with TLR2/6 is required
for effective activation of the inflammatory response to LTA.
CD36 null mice fail to clear S. aureus 
in vivo
To establish the role of CD36 in the innate immune response to
bacteria, Cd36
 /  and wild-type mice were infected intrave-
nously with S. aureus and E. coli (Fig. 7 a). When infected with
encapsulated  S. aureus (Reynolds strain), Cd36
 /  failed to
clear the initial bacteraemia, resulting in a mean bacterial load
of 3.8   10
9 S. aureus colony forming units per milliliter of
blood on day 4 (Fig. 7 b). In contrast, wild-type mice had effi-
ciently cleared the S. aureus and no circulating bacteria were
detectable. Furthermore, 20% of Cd36
 /  mice died 6–8 d after
inoculation, whereas all wild-type mice survived the infection
(Fig. 7 a). Necropsy examination of these mice on day 22 dem-
onstrated that the prolonged early bacteraemia in Cd36
 /  mice
resulted in abscess formation in 50% of the animals (Fig. 7 c).
In contrast, only 1 of 10 wild-type mice had an apparent ab-
scess of the kidney, indicating that these mice had successfully
cleared the bacteria. Thus, loss of CD36-mediated clearance
and cytokine signaling appeared to have profound biological
consequences on the host response to S. aureus infection. In un-
encapsulated S. aureus strains, LTA is exposed on the bacterial
cell surface. As CD36 directly recognizes LTA, we hypothesized
Figure 5. CD36 is required for LTA-induced cytokine production. Peritoneal
macrophages from wild-type and Cd36
 /  mice were incubated with 100
ng/ml LTA or LPS for 6 h, and cytokine mRNA (a) and protein (b) expres-
sion was determined by quantitative RT-PCR and ELISA, respectively. *, P  
0.05; **, P   0.005, significantly different from wild-type macrophages.
Figure 6. CD36-mediated internalization by
the COOH-terminal cytoplasmic domain is re-
quired for engagement of TLR2/6 signaling.
(a) CD36 cooperates with TLR2/TLR6 to ini-
tiate NF B activation in response to LTA.
HEK293-TLR2 or -TLR9 cells expressing NF B
reporter constructs and CD36, TLR6, or both
were stimulated with 1  g/ml LTA for 5 h, and
cell lysates were analyzed for luciferase activ-
ity. (b) CD36 initiates TLR2/6-mediated NF B
activation in response to S. aureus and LTA.
HEK293-TLR2 cells expressing NF B reporter
constructs and CD36, TLR6, or both were stim-
ulated with 1  g/ml LTA or S. aureus (10:1)
for 5 h, and cell lysates were analyzed for lu-
ciferase activity as described in (a). (c) CD36-
mediated TLR2/6-NF B activation requires
internalization of LTA. HEK293-TLR2 cells ex-
pressing NF B-luciferase reporter constructs
and CD36, TLR6, or both were pretreated with
1  g/ml cytochalasin D for 30 min before stim-
ulation with LTA as described in (a). (d and e)
Mutations that block CD36-mediated internal-
ization of LTA inhibit TLR2/6 signaling. (d)
HEK-293 cells were transfected with wild-type
CD36 or CD36 mutant constructs and inter-
nalization of BODIPY-LTA (10  g/ml) was
measured by flow cytometry in the presence
of trypan blue. (e) HEK293-TLR2 cells express-
ing NF B reporter constructs and wild-type or
mutant CD36 constructs with TLR6 were stimu-
lated with LTA for 5 h, and NF B-luciferase ex-
pression was measured. (f) Cytochalasin D
treatment does not block TLR2/6 signaling by CD36 internalization-defective mutants. HEK293-TLR2 cells expressing NF B reporter constructs, TLR6, and
wild-type or mutant CD36 were pretreated with 1  g/ml cytochalasin D for 30 min before stimulation with LTA, and cell lysates were analyzed for luciferase
activity as described in (a). Data presented are the mean of triplicate samples   SD. **, P   0.005.JCB • VOLUME 170 • NUMBER 3 • 2005 482
that it may make a greater contribution to host defense against
unencapsulated S. aureus. When injected with the unencapsu-
lated S. aureus strain 3825-4 (CP5
 ), 50% of Cd36
 /  mice
succumbed to the infection, whereas all wild-type mice sur-
vived (Fig. 7 a). Furthermore, 100% of the surviving Cd36
 / 
mice developed perinephric and/or pericardial abscesses. Simi-
lar experiments using E. coli failed to demonstrate any signifi-
cant difference in the survival of wild-type and CD36 null
mice, indicating that this was not a nonspecific immune pare-
sis, but rather that CD36 has an important and nonredundant
role in combating S. aureus infection, particularly those unen-
capsulated strains in which LTA is exposed.
Discussion
In a forward genetic screen, we identify that Croquemort, a
Drosophila SR, plays a specific role in the phagocytosis of S.
aureus, demonstrating for the first time that the members of
this family of CD36-related molecules act as phagocytic recep-
tors for bacteria. We extend this initial observation to confirm
that the mammalian paralogue of Croquemort, CD36, also di-
rectly phagocytoses bacteria and plays a role in the host im-
mune response to S. aureus. Transfection of cells with CD36
confers the ability to bind and internalize both S. aureus and E.
coli; however, macrophages deficient in CD36 are impaired
only in their ability to phagocytose S. aureus. Through structure–
function analysis, we show that CD36-mediated internalization
of S. aureus and LTA is dependent on the COOH-terminal cy-
toplasmic portion of this receptor proposed to interact with
signaling molecules. Mutations of the cytoplasmic residues,
specifically tyrosine 463, abolish CD36-mediated phagocyto-
sis, but not binding, indicating that this domain is essential to
signal to the actin cytoskeleton and trigger engulfment. Further-
more, in the absence of CD36, macrophages show a profound
defect in cytokine production in response to both S. aureus and
its cell wall component (LTA). In vivo, CD36 null mice fail to
efficiently clear S. aureus, resulting in profound bacteraemia
and abscess formation. Recent data has identified a role for
CD36 in the recognition of diacylglycerides and in the activa-
tion of signaling via TLR2 and TLR6 (Hoebe et al., 2005).
However, the mechanism by which CD36 augments this re-
sponse is unknown. We now show that CD36-mediated inter-
nalization of LTA, mediated by its cytoplasmic tail, is required
to fully activate TLR2/6 signaling. Our data suggest that CD36
functions to both clear circulating bacteria and to bind bacterial
ligands where they may be presented to TLR signaling path-
ways either at the cell surface or the phagosome.
Microbial internalization is accompanied by inflammatory
responses that are driven by TLR signaling pathways. Particles
are internalized into a membrane-limited organelle, the pha-
gosome, which matures into a highly hydrolytic environment
facilitating degradation of internalized bacteria into their
component parts. Although TLRs are not believed to function
directly as phagocytic receptors, many TLRs are recruited to the
newly formed phagosome after particle ingestion, where they
are thought to “sample” the phagosome for microbial ligands
(Underhill et al., 1999; Underhill and Gantner, 2004). Thus,
CD36-mediated delivery of S. aureus to this organelle might fa-
cilitate the release of ligands such as LTA from the cell wall,
thereby delivering these particles to TLRs to initiate inflamma-
tory signaling and cytokine production. On the cell surface,
CD36 would be able to cluster LTA released from S. aureus af-
ter exposure to antibiotics or leukocytic mediators, coordinating
engagement of TLRs at the cell surface in a manner similar to
CD14. An alternative hypothesis is that CD36 may mediate its
effects independent of TLR signaling pathways. However,
CD36 transfection alone was insufficient to stimulate NF B ac-
tivation in response to S. aureus or LTA, suggesting that CD36
cooperates with TLRs to initiate NF B signaling. The major-
ity of the CD36 protein forms an extracellular loop contain-
ing distinct ligand binding domains, and its short NH2- and
COOH-terminal cytoplasmic tails are palmitoylated, localizing
this receptor to lipid rafts (Tao et al., 1996). These domains are
rich in signaling molecules, and CD36 has been shown to inter-
act with Src kinase family members that reside in lipid rafts to
engage downstream signaling cascades, including p38 and p44/
42 MAPK pathways (Huang et al., 1991; Jimenez et al., 2000;
McGilvray et al., 2000; Moore et al., 2002; Bamberger et al.,
2003; Medeiros et al., 2004). Recent work has highlighted the
importance of MAPK pathways in regulating endocytosis,
Figure 7. CD36 null mice are more susceptible to S. aureus and fail to
clear circulating bacteria. (a) Wild-type and Cd36
 /  mice were inocu-
lated i.v. with S. aureus (capsular strain Reynolds or the unencapsulated
3825-4 strain) or E. coli (018K) and monitored for survival. (b) Cd36
 / 
mice fail to effectively clear S. aureus. Blood collected from the tail vein af-
ter 4 d was cultured on tryptic soy agar plates supplemented with 5%
sheep’s blood and the mean colony forming units were counted from each
mouse. Representative bacterial plates are presented. (c) Cd36
 /  mice
develop perinephric and pericardial abscesses. Necropsies performed on
surviving mice showed abundant abscess formation in the hearts and kid-
neys of Cd36
 /  mice (absolute numbers reported in panel a). Arrowhead
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phagocytosis, and phagosome maturation in both macrophages
and dendritic cells (Blander and Medzhitov, 2004; West et al.,
2004). Thus, it is also possible that CD36 regulation of MAPK
pathways contributes to augment S. aureus– and LTA-induced
cytokine production. However, the CD36 residues vital for aug-
mentation of TLR2/6 signaling in response to LTA (Y463 and
C464) are not required for CD36-mediated activation of MAPK
by its other ligands,  -amyloid and oxidized low-density lipo-
protein (unpublished data). Together, these data provide compel-
ling evidence that CD36-mediated internalization is an impor-
tant mechanism by which it augments TLR2/6 signaling.
Phagocyte recognition of foreign or modified ligands,
such as bacteria and apoptotic cells, is an essential component
of both the innate and adaptive immune responses. Particle rec-
ognition and internalization is mediated by a variety of phago-
cytic receptors including the Fc  receptor, CR3, the mannose
receptor, and members of the SR family, including SR-A,
LOX-1, and MARCO (Mukhopadhyay and Gordon, 2004; Un-
derhill and Gantner, 2004). Engagement of these receptors ulti-
mately results in activation of RhoGTPases, including Rac, to
induce cytoskeletal reorganization, actin polymerization, and
particle internalization (Cox et al., 1997). Although, CD36 and
its  Drosophila homologue Croquemort have been shown to
mediate binding of apoptotic cells (Savill et al., 1992; Ren et
al., 1995; Franc et al., 1999), it was unclear whether CD36
alone was sufficient to trigger engulfment. We have recently
found that  -amyloid engagement of CD36 leads to assembly
of focal adhesion molecules that act upstream of Rac1, includ-
ing p130cas, Pyk2, and paxillin (unpublished data). These ob-
servations lead us to hypothesize that CD36, either alone or in
cooperation with a coreceptor, can regulate downstream targets
such as Rac and the actin cytoskeleton to mediate internaliza-
tion. Our finding that expression of CD36 confers both binding
and internalization of bacteria supports this role of CD36 as a
phagocytic receptor. Furthermore, in Drosophila S2 cells, the
absence of Croquemort and Rac2 causes a similar degree of in-
hibition of S. aureus, but not E. coli phagocytosis, suggesting
that these molecules may function in the same pathway to sig-
nal engulfment. Importantly, we show that the COOH-terminal
cytoplasmic residues of CD36 are essential to trigger phago-
cytic engulfment, indicating that several of the human CD36
mutations known to lack this region are unlikely to support in-
ternalization or activation in response to S. aureus or LTA.
However, whether this domain of CD36 interacts directly with
the actin cytoskeleton through adaptor molecules such as
p130Cas, or whether it recruits coreceptors such as the inte-
grins to perform this function, remains to be determined.
To investigate the in vivo consequences of lack of CD36-
mediated phagocytosis and signaling, we used mice with a tar-
geted deletion of CD36. We demonstrate that loss of CD36 has
profound biological consequences on the early response to S.
aureus infection, particularly in the ability to mount a response
to an unencapsulated strain (3825-4) of this pathogen. Cd36
 / 
mice exhibit 5–8 log order greater bacterial loads, which ulti-
mately lead to perinephric and pericardial abscess formation.
However, although CD36 is essential for early responses to
S. aureus and LTA, including macrophage phagocytosis and
cytokine responses, alternative pathways appear to compensate
to protect the host against S. aureus–induced lethality, indicat-
ing that the innate immune system has evolved overlapping
mechanisms to combat this important pathogen. Several other
molecules have been implicated in the immune response to S.
aureus, including the SRs AI and II and soluble opsonins such
as mannose-binding lectin, thrombospondin, and LPS-binding
protein (Dunne et al., 1994; Haworth et al., 1997; Thomas et
al., 2000; Schroder et al., 2003; Mukhopadhyay and Gordon,
2004; Shi et al., 2004), emphasizing the complexity of this in
vivo model system.
Interestingly, CD36 did appear to play a small role in re-
sponse to E. coli, as TNF  and IL-6 secretion by macrophages
was decreased in its absence. However, macrophage TNF 
production in response to isolated LPS did not require CD36.
Importantly, neither E. coli engulfment by macrophages nor in
vivo host response was compromised by the absence of CD36,
indicating a specific failure to respond to S. aureus rather than
a general immune depression. It is likely that in these complex
and partially redundant systems, other receptors such as the
LPS receptor CD14 and CD11b/CD18 are more important to
mediate host cytokine responses to E. coli. Nonetheless, that
CD36 binds both Gram-negative and -positive bacteria is en-
tirely consistent with its function as a multi-ligand SR.
The data presented demonstrate that CD36 acts as a
phagocytic receptor able to recognize S. aureus and its cell wall
component LTA. These data demonstrate that CD36 functions
in a capacity analogous to the LPS receptor CD14, clustering
LTA at the cell surface where it may engage TLR2 and TLR6.
Moreover, CD36 has the additional capacity to internalize
whole S. aureus and LTA, concentrating them in the phago-
some or endosome where they can also engage TLR signaling
pathways. This internalization is vital for full activation of
TLR2/6 signaling in response to LTA. Loss of this ability to in-
ternalize ligands in individuals with CD36 mutations altering
the COOH-terminal cytoplasmic domain would be predicted to
impair the host response, rendering these individuals more sus-
ceptible to S. aureus infection. These findings provide a novel
mechanism likely to be common to many SRs that links host
detection of pathogens to engagement of TLR signaling path-
ways, both at the cell surface and intracellularly, to activate
host proinflammatory responses.
Materials and methods
Mice
The Cd36
 /  mice (backcrossed nine generations to C57BL/6J) were gen-
erated in our laboratory as described, and Cd36
 /  mice were generated
from Cd36
 /  intercrosses (Moore et al., 2002). All mice were maintained
in a pathogen-free facility with free access to rodent chow and water.
Experimental procedures were approved by the Massachusetts General
Hospital’s Subcommittee on Research Animal Care and were conducted
in accordance with the US Department of Agriculture Animal Welfare Act
and the Public Health Service Policy for the Humane Care and Use of
Laboratory Animals.
Peritoneal macrophage culture
Elicited peritoneal macrophages were collected from mice by peritoneal la-
vage 4 d after i.p. injection with 3% thioglycollate as described previously
(Moore et al., 2002) and cultured in DME containing 2% FBS, 100 U/ml
penicillin, and 100  g/ml streptomycin overnight at 37 C before use.JCB • VOLUME 170 • NUMBER 3 • 2005 484
Transfection assays
COOH-terminal mutations of the murine CD36 cDNA (Fig. 2 a) were
generated by PCR, verified by sequencing, and cloned into the
pcDNA3.1 vector containing a CMV promoter. HEK293 EBNA T cells
were maintained in DME containing 10% FBS, 100 U/ml penicillin, and
100  g/ml streptomycin and were cultured in medium lacking penicillin
and streptomycin for 24 h before transfection. Cells (6   10
5 cells/well;
6-well plate) were transfected with pcDNA 3.1 plasmids containing wild-
type or mutant CD36 cDNAs, or no insert (mock), in OptiMEM contain-
ing Lipofectamine 2000 as previously described (Kim et al., 2004).
Equivalent expression of wild-type and mutant CD36 was confirmed 48 h
after transfection by flow cytometry using a monoclonal anti-murine
CD36 antibody (1:650 dilution; Cascade Biologics, Inc.) and an anti–
mouse IgA-FITC secondary antibody (1:200 dilution; BD Biosciences) as
previously described (Medeiros et al., 2004). The anti-CD36 antibody
recognizes an epitope in the extracellular portion of CD36 that is not af-
fected by the mutations generated.
Fluorescent labeling of LTA
LTA preparations from S. aureus (Sigma-Aldrich) were labeled with 4,4-
difluoro-1,3-dimethyl-5-(4-methoxyphenyl)-4-bora-3a,4a-diaza-S-indacene-
2-propionoyl-tetramethyl-rhodamine (BODIPY-TMR; Molecular Probes Inc.)
using the manufacturer’s protocol for oligosaccharide labeling as previ-
ously described (Levels et al., 2003).
RNAi treatment
Double stranded RNA interference was used to specifically silence genes
in Drosophila S2 cells as described previously (Ramet et al., 2002). Dro-
sophila S2 cells were cultured in Schneider’s Drosophila media (GIBCO
BRL) at 26 C. S2 cells (10
6) were treated with 15  g dsRNA for 60 h and
viability was confirmed by trypan blue exclusion. The ability of RNAi-
treated cells to phagocytose heat-killed FITC-labeled S. aureus and E. coli
(Molecular Probes) was measured using flow cytometry as described in
the following section and compared with cells treated with irrelevant GFP
control dsRNA. dsRNA was generated by in vitro transcription from a PCR
amplicon either from cDNA, template plasmids, or PCR products using
gene-specific primers flanked by a T7 polymerase site. Primer sequences
were as follows: GFP forward T7, CCTACATACCTCGCTCTGC; GFP re-
verse T7, GCGCTTTCTCATAGCTCAC; Crq forward T7, TTGTACGTAAC-
CAAGCCG; Crq reverse T7, CTTCATTCCACTGACAGCA;  Rac1 for-
ward T7, TCAGCTACACGACCAATGCCTTTC; Rac1 reverse T7,
CAGATACTTGACCGCTCCGATTTC; Rac2 forward T7, GGCCATCAAG-
TGTGTGGTTGTGGG; Rac2 reverse T7, CATCGCCAGTCCTTGGGGAT-
AGGT.
Phagocytosis assays
Quantification of binding and uptake of heat-killed FITC-labeled S. aureus
and E. coli (both from Molecular Probes) was performed as described pre-
viously (Ramet et al., 2002; Shi et al., 2004). In brief, 2   10
5 cells in
48-well plates were cooled to 4 C for 20 min, 2   10
6 bacteria were
added for 30 min at 4 C, and then cells were incubated at 37 C (26 C
for S2 cells) for 30 min to allow internalization. Cells were placed on ice
to stop internalization and were maintained on ice for the remainder of
the assay. Total cell-associated fluorescence (binding and uptake) was
measured by flow cytometry (10,000 events) using the CellQuest program
(Becton Dickinson). Bacterial internalization was measured by quenching
extracellular fluorescence with 0.2% trypan blue shortly before analysis.
Binding was calculated as the difference between total cell-associated
fluorescence and intracellular fluorescence. The amount of phagocytosis
(phagocytic index) was expressed as the percentage of fluorescence-posi-
tive cells multiplied by the mean fluorescence of these cells. All treatments
were performed in triplicate and data are presented as the mean   SD.
Microscopy
Peritoneal macrophages were allowed to adhere to glass coverslips for 1 h
before the addition of bacteria at a ratio of 10:1. FITC-bacteria were spun
onto the cells, and phagocytosis was synchronized by first binding on ice
for 30 min. Cells were then warmed to 37 C for 30 min. Internalization
was stopped by vigorously washing, and cells were fixed using formal-
dehyde before mounting with Vectashield fluorescent mounting medium
containing DAPI stain (Vector Laboratories). Slides were imaged on an
inverted fluorescent microscope (model TE 2000-U; Nikon) equipped
with a camera (Nikon) using Openlab software (version 4.0.2), original
magnification  40, NA 0.60, at RT. After acquisition, manipulation of
brightness, color balance, and contrast was applied uniformly across im-
ages using Adobe Photoshop software.
Measurement of cytokine expression
TNF , IL-12, and IL-6 mRNA levels were measured by real-time quantita-
tive RT-PCR using an iCycler (Bio-Rad Laboratories) as described previously
(Medeiros et al., 2004). Total RNA was extracted using Trizol reagent and
reverse transcribed using Moloney Murine Leukemia Virus reverse tran-
scriptase. Each reaction contained 3  l cDNA, 0.3  M TNF , IL-12, IL-6,
or GAPDH primers, SYBR green (QIAGEN), and HotStarTaq polymerase.
PCR conditions were 15 min at 95 C, followed by 30 cycles of 30 s at
95 C, 30 s at 55 C, and 30 s at 72 C. Each sample was analyzed in trip-
licate and the amount of mRNA in each sample was calculated from a
standard curve of known template and normalized to GAPDH. The amount
of TNF , IL-12, and IL-6 protein in cell culture supernatants was measured
by ELISA (R&D Systems) as described previously (Shi et al., 2004). Data
are presented as the mean of triplicate samples   SD.
NF B-luciferase reporter assays
Dual luciferase reporter assays for NF B activation were performed in
HEK293 cells that stably express TLR2 or TLR9 (provided by D. Golenbock,
University of Massachusetts Medical School, Worcester, MA) as previ-
ously described (Latz et al., 2002). Cells were transfected with a NF B-
luciferase reporter construct and/or pcDNA3.1-CD36 and/or TLR6 cDNAs
using lipofectamine 2000 as per the manufacturer’s instructions. Before
assays, equivalent expression of CD36 and TLR6 was confirmed in all
samples. The cells were stimulated with 1  g/ml LTA or S. aureus (10:1)
for 5 h and lysed, and reporter gene activity was measured using the Dual
Luciferase Assay Reporter System (Promega) using a plate-reader luminom-
eter. Data were normalized to cellular protein. In some assays, cells were
treated with 1  g/ml cytochalasin D (Sigma-Aldrich) for the duration of
the assay. The data shown represent one of at least four separate experi-
ments and are presented as the mean values   SD of triplicate samples.
Bacterial infection in vivo
S. aureus was grown overnight in Columbia medium with 2% NaCl and
resuspended in saline. Wild-type and Cd36
 /  mice (n   10; 6–8 wk old)
were inoculated with S. aureus Reynolds capsular serotype 5 (10
7), unen-
capsulated S. aureus 3825-4 strain (2   10
7), or E. coli 018K (5   10
6)
by tail vein injection and monitored for survival and complications from in-
fection as described previously (Shi et al., 2004). Moribund animals were
killed by CO2 inhalation. In mice injected with S. aureus, blood was col-
lected from the tail vein after 4 and 15 d and mixed with heparin, and se-
rial dilutions of the blood were cultured on tryptic soy agar plates supple-
mented with 5% sheep’s blood to determine the number of S. aureus
colony forming units. Necropsies were performed on surviving mice at the
end of the study and abscess formation was quantified.
Statistical analysis
Quantitative data are expressed as the mean   SD of triplicate samples
and are representative of at least three separate experiments. The differ-
ence between two groups was statistically analyzed by t test or an analy-
sis of variance (one-way ANOVA). A p-value of  0.05 was considered
significant. Survival data was analyzed using Log-Rank and Wilcoxon
tests using JMP5 software (SAS Institute, Inc.).
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